Free Trial

Novanta (NASDAQ:NOVT) Issues FY 2025 Earnings Guidance

Novanta logo with Computer and Technology background

Key Points

  • Novanta has issued its FY 2025 earnings guidance, projecting EPS between $3.220 and $3.360, slightly below the consensus estimate of $3.370.
  • The company's stock experienced a decline of 4.3%, closing at $118.66 despite reporting better-than-expected quarterly earnings results recently.
  • Analysts have upgraded Novanta from a "hold" rating to a "buy" rating, indicating a positive outlook for the company's future performance.
  • Five stocks to consider instead of Novanta.

Novanta (NASDAQ:NOVT - Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 3.220-3.360 for the period, compared to the consensus EPS estimate of 3.370. The company issued revenue guidance of $970.0 million-$985.0 million, compared to the consensus revenue estimate of $983.2 million. Novanta also updated its Q3 2025 guidance to 0.780-0.850 EPS.

Novanta Stock Down 4.3%

NASDAQ NOVT traded down $5.35 during trading hours on Tuesday, reaching $118.66. 607,377 shares of the company's stock were exchanged, compared to its average volume of 276,216. The company's 50-day moving average is $126.07 and its two-hundred day moving average is $130.08. The company has a market capitalization of $4.27 billion, a price-to-earnings ratio of 60.44 and a beta of 1.48. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.70 and a current ratio of 2.56. Novanta has a one year low of $98.76 and a one year high of $186.75.

Novanta (NASDAQ:NOVT - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The technology company reported $0.76 earnings per share for the quarter, beating the consensus estimate of $0.74 by $0.02. Novanta had a net margin of 7.42% and a return on equity of 15.06%. The firm had revenue of $241.05 million for the quarter, compared to analysts' expectations of $237.97 million. During the same period in the prior year, the firm earned $0.73 EPS. The business's revenue was up 2.2% on a year-over-year basis. On average, analysts forecast that Novanta will post 3.03 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, Wall Street Zen raised Novanta from a "hold" rating to a "buy" rating in a research report on Sunday.

View Our Latest Research Report on NOVT

Hedge Funds Weigh In On Novanta

Several hedge funds and other institutional investors have recently modified their holdings of NOVT. Jane Street Group LLC raised its stake in Novanta by 1,762.5% in the 1st quarter. Jane Street Group LLC now owns 61,631 shares of the technology company's stock valued at $7,881,000 after purchasing an additional 58,322 shares during the last quarter. Goldman Sachs Group Inc. lifted its stake in Novanta by 1.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 419,037 shares of the technology company's stock worth $53,582,000 after purchasing an additional 6,533 shares in the last quarter. Finally, AQR Capital Management LLC boosted its holdings in shares of Novanta by 78.9% during the 1st quarter. AQR Capital Management LLC now owns 4,231 shares of the technology company's stock worth $537,000 after purchasing an additional 1,866 shares during the last quarter. 98.35% of the stock is owned by institutional investors.

Novanta Company Profile

(Get Free Report)

Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Novanta Right Now?

Before you consider Novanta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novanta wasn't on the list.

While Novanta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines